Role of Interleukin-6 and Procalcitonin as Novel Inflammatory Biomarkers in Evaluating COVID 19 Disease Severity - an Experience at CMH Quetta

NCT04945811 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Covid19 Positive Patients

Interventions

DIAGNOSTIC_TEST: Interlukein 6 and procalcitonin serum levels

Sponsor

FARAH AFZAL